|
시장보고서
상품코드
1557628
세계의 생물학적 치료제 시장(2024-2028년)Global Biologic Therapeutics Market 2024-2028 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
생물학적 치료제 시장은 2023-2028년간 3,983억 달러 확대되고, 예측 기간 중 연평균 복합 성장률(CAGR)은 13.64%를 나타낼 전망입니다.
생물학적 치료제 시장에 대한 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 게재했습니다.
현재의 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공합니다. 바이오시밀러 서론, 만성질환이나 면역질환 증가, 주요 생물제제의 특허 만료 등이 시장 성장을 촉진하고 있습니다.
| 시장 범위 | |
|---|---|
| 기준년 | 2024년 |
| 종료년 | 2028년 |
| 예측 기간 | 2024-2028년 |
| 성장 모멘텀 | 가속 |
| YOY 2024 | 11.73% |
| CAGR | 13.64% |
| 증분액 | 3,983억 달러 |
본 조사에서는 강력한 연구개발 파이프라인이 향후 몇 년간 생물학적 치료제 시장 성장을 가속하는 주요인 중 하나로 보고 있습니다. 또한 생물학적 제제 표적 치료 메커니즘이나 생물학적 제제 개발에 대한 투자 증가는 시장의 큰 수요로 연결될 것입니다.
목차
제1장 주요 요약
- 시장 개요
제2장 시장 구도
- 시장 생태계
- 시장 특징
- 밸류체인 분석
제3장 시장 규모 평가
- 시장의 정의
- 시장 부문 분석
- 시장 규모(2023년)
- 시장 전망(2023-2028년)
제4장 시장 규모 실적
- 세계의 생물학적 치료제 시장(2018-2022년)
- 용도별 부문 분석(2018-2022년)
- 제품별 부문 분석(2018-2022년)
- 지역별 부문 분석(2018-2022년)
- 국가별 부문 분석(2018-2022년)
제5장 Five Forces 분석
- Five Forces 요약
- 바이어의 교섭력
- 공급 기업의 교섭력
- 신규 진출업체의 위협
- 대체품의 위협
- 경쟁 위협
- 시장 현황
제6장 시장 세분화 : 용도별
- 시장 세분화
- 비교 : 용도별
- 암 : 시장 규모와 예측(2023-2028년)
- 감염증 : 시장 규모와 예측(2023-2028년)
- 자가면역질환 : 시장 규모와 예측(2023-2028년)
- 기타 : 시장 규모와 예측(2023-2028년)
- 시장 기회 : 용도별
제7장 시장 세분화 : 제품별
- 시장 세분화
- 비교 : 제품별
- 항체 치료 : 시장 규모와 예측(2023-2028년)
- 백신 : 시장 규모와 예측(2023-2028년)
- 세포 치료 : 시장 규모와 예측(2023-2028년)
- 유전자 치료 : 시장 규모와 예측(2023-2028년)
- 기타 : 시장 규모와 예측(2023-2028년)
- 시장 기회 : 제품별
제8장 고객 상황
- 고객 상황 개요
제9장 지역별 상황
- 지역별 세분화
- 지역별 비교
- 북미 : 시장 규모와 예측(2023-2028년)
- 유럽 : 시장 규모와 예측(2023-2028년)
- 아시아 : 시장 규모와 예측(2023-2028년)
- 세계 기타 지역 : 시장 규모와 예측(2023-2028년)
- 미국 : 시장 규모와 예측(2023-2028년)
- 중국 : 시장 규모와 예측(2023-2028년)
- 독일 : 시장 규모와 예측(2023-2028년)
- 프랑스 : 시장 규모와 예측(2023-2028년)
- 일본 : 시장 규모와 예측(2023-2028년)
- 시장 기회 : 지역 상황별
제10장 성장 촉진요인, 과제, 기회 및 성장 억제요인
- 시장 성장 촉진요인
- 시장이 해결해야 할 과제
- 성장 촉진요인과 과제의 영향
- 시장 기회와 시장 성장 억제요인
제11장 경쟁 구도
- 개요
- 경쟁 구도
- 혼란 상황
- 업계 리스크
제12장 경쟁 분석
- 기업 개요
- 기업의 시장 포지셔닝
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca Plc
- Aurobindo Pharma Ltd.
- Baxter International Inc.
- Biocon Ltd.
- Celltrion Healthcare Co. Ltd.
- Eli Lilly and Co.
- GlaxoSmithKline Plc
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.
- Precision Biologics Inc.
- Samsung Electronics Co. Ltd.
- Sanofi SA
제13장 부록
LSH 24.10.10The biologic therapeutics market is forecasted to grow by USD 398.3 bn during 2023-2028, accelerating at a CAGR of 13.64% during the forecast period. The report on the biologic therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by introduction of biosimilars, increasing incidence of chronic diseases and immunological disorders, and patent expiry of major biologics.
Technavio's biologic therapeutics market is segmented as below:
| Market Scope | |
|---|---|
| Base Year | 2024 |
| End Year | 2028 |
| Series Year | 2024-2028 |
| Growth Momentum | Accelerate |
| YOY 2024 | 11.73% |
| CAGR | 13.64% |
| Incremental Value | $398.3bn |
By Application
- Cancer
- Infectious diseases
- Autoimmune diseases
- Others
By Product
- Antibody therapeutics
- Vaccines
- Cell therapy
- Gene therapy
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the strong research and development pipeline as one of the prime reasons driving the biologic therapeutics market growth during the next few years. Also, targeted therapeutic mechanism of biologics and increasing investment in developing biologics will lead to sizable demand in the market.
The report on the biologic therapeutics market covers the following areas:
- Biologic therapeutics market sizing
- Biologic therapeutics market forecast
- Biologic therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biologic therapeutics market vendors that include AbbVie Inc., Amgen Inc., Apogenix AG, AstraZeneca Plc, Aurobindo Pharma Ltd., Baxter International Inc., Biocon Ltd., BioMarin Pharmaceutical Inc., Celltrion Healthcare Co. Ltd., Eli Lilly and Co., GangaGen Biotechnologies Pvt Ltd., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., Precision Biologics Inc., Samsung Electronics Co. Ltd., Sanofi SA, and Tubulis GmbH. Also, the biologic therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 2.2 Market characteristics
- Market characteristics analysis
- 2.3 Value chain analysis
- Value Chain Analysis
3 Market Sizing
- 3.1 Market definition
- Offerings of companies included in the market definition
- 3.2 Market segment analysis
- Market segments
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
- 4.1 Global Biologic Therapeutics Market 2018 - 2022
- Historic Market Size - Data Table on Global Biologic Therapeutics Market 2018 - 2022 ($ billion)
- 4.2 Application segment analysis 2018 - 2022
- Historic Market Size - Application Segment 2018 - 2022 ($ billion)
- 4.3 Product segment analysis 2018 - 2022
- Historic Market Size - Product Segment 2018 - 2022 ($ billion)
- 4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
- 4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
- 5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application
- 6.1 Market segments
- Chart on Application - Market share 2023-2028 (%)
- Data Table on Application - Market share 2023-2028 (%)
- 6.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
- 6.3 Cancer - Market size and forecast 2023-2028
- Chart on Cancer - Market size and forecast 2023-2028 ($ billion)
- Data Table on Cancer - Market size and forecast 2023-2028 ($ billion)
- Chart on Cancer - Year-over-year growth 2023-2028 (%)
- Data Table on Cancer - Year-over-year growth 2023-2028 (%)
- 6.4 Infectious diseases - Market size and forecast 2023-2028
- Chart on Infectious diseases - Market size and forecast 2023-2028 ($ billion)
- Data Table on Infectious diseases - Market size and forecast 2023-2028 ($ billion)
- Chart on Infectious diseases - Year-over-year growth 2023-2028 (%)
- Data Table on Infectious diseases - Year-over-year growth 2023-2028 (%)
- 6.5 Autoimmune diseases - Market size and forecast 2023-2028
- Chart on Autoimmune diseases - Market size and forecast 2023-2028 ($ billion)
- Data Table on Autoimmune diseases - Market size and forecast 2023-2028 ($ billion)
- Chart on Autoimmune diseases - Year-over-year growth 2023-2028 (%)
- Data Table on Autoimmune diseases - Year-over-year growth 2023-2028 (%)
- 6.6 Others - Market size and forecast 2023-2028
- Chart on Others - Market size and forecast 2023-2028 ($ billion)
- Data Table on Others - Market size and forecast 2023-2028 ($ billion)
- Chart on Others - Year-over-year growth 2023-2028 (%)
- Data Table on Others - Year-over-year growth 2023-2028 (%)
- 6.7 Market opportunity by Application
- Market opportunity by Application ($ billion)
- Data Table on Market opportunity by Application ($ billion)
7 Market Segmentation by Product
- 7.1 Market segments
- Chart on Product - Market share 2023-2028 (%)
- Data Table on Product - Market share 2023-2028 (%)
- 7.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
- 7.3 Antibody therapeutics - Market size and forecast 2023-2028
- Chart on Antibody therapeutics - Market size and forecast 2023-2028 ($ billion)
- Data Table on Antibody therapeutics - Market size and forecast 2023-2028 ($ billion)
- Chart on Antibody therapeutics - Year-over-year growth 2023-2028 (%)
- Data Table on Antibody therapeutics - Year-over-year growth 2023-2028 (%)
- 7.4 Vaccines - Market size and forecast 2023-2028
- Chart on Vaccines - Market size and forecast 2023-2028 ($ billion)
- Data Table on Vaccines - Market size and forecast 2023-2028 ($ billion)
- Chart on Vaccines - Year-over-year growth 2023-2028 (%)
- Data Table on Vaccines - Year-over-year growth 2023-2028 (%)
- 7.5 Cell therapy - Market size and forecast 2023-2028
- Chart on Cell therapy - Market size and forecast 2023-2028 ($ billion)
- Data Table on Cell therapy - Market size and forecast 2023-2028 ($ billion)
- Chart on Cell therapy - Year-over-year growth 2023-2028 (%)
- Data Table on Cell therapy - Year-over-year growth 2023-2028 (%)
- 7.6 Gene therapy - Market size and forecast 2023-2028
- Chart on Gene therapy - Market size and forecast 2023-2028 ($ billion)
- Data Table on Gene therapy - Market size and forecast 2023-2028 ($ billion)
- Chart on Gene therapy - Year-over-year growth 2023-2028 (%)
- Data Table on Gene therapy - Year-over-year growth 2023-2028 (%)
- 7.7 Others - Market size and forecast 2023-2028
- Chart on Others - Market size and forecast 2023-2028 ($ billion)
- Data Table on Others - Market size and forecast 2023-2028 ($ billion)
- Chart on Others - Year-over-year growth 2023-2028 (%)
- Data Table on Others - Year-over-year growth 2023-2028 (%)
- 7.8 Market opportunity by Product
- Market opportunity by Product ($ billion)
- Data Table on Market opportunity by Product ($ billion)
8 Customer Landscape
- 8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
- 9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ billion)
- Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 9.8 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ billion)
- Data Table on China - Market size and forecast 2023-2028 ($ billion)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
- 9.9 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ billion)
- Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 9.10 France - Market size and forecast 2023-2028
- Chart on France - Market size and forecast 2023-2028 ($ billion)
- Data Table on France - Market size and forecast 2023-2028 ($ billion)
- Chart on France - Year-over-year growth 2023-2028 (%)
- Data Table on France - Year-over-year growth 2023-2028 (%)
- 9.11 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ billion)
- Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)
- 9.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ billion)
- Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Opportunity/Restraints
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 10.4 Market opportunities/restraints
11 Competitive Landscape
- 11.1 Overview
- 11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 11.3 Landscape disruption
- Overview on factors of disruption
- 11.4 Industry risks
- Impact of key risks on business
12 Competitive Analysis
- 12.1 Companies profiled
- Companies covered
- 12.2 Market positioning of companies
- Matrix on companies position and classification
- 12.3 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- 12.4 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- 12.5 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- 12.6 Aurobindo Pharma Ltd.
- Aurobindo Pharma Ltd. - Overview
- Aurobindo Pharma Ltd. - Product / Service
- Aurobindo Pharma Ltd. - Key offerings
- 12.7 Baxter International Inc.
- Baxter International Inc. - Overview
- Baxter International Inc. - Business segments
- Baxter International Inc. - Key news
- Baxter International Inc. - Key offerings
- Baxter International Inc. - Segment focus
- 12.8 Biocon Ltd.
- Biocon Ltd. - Overview
- Biocon Ltd. - Business segments
- Biocon Ltd. - Key offerings
- Biocon Ltd. - Segment focus
- 12.9 Celltrion Healthcare Co. Ltd.
- Celltrion Healthcare Co. Ltd. - Overview
- Celltrion Healthcare Co. Ltd. - Business segments
- Celltrion Healthcare Co. Ltd. - Key offerings
- Celltrion Healthcare Co. Ltd. - Segment focus
- 12.10 Eli Lilly and Co.
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key news
- Eli Lilly and Co. - Key offerings
- 12.11 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- 12.12 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- 12.13 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- 12.14 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- 12.15 Precision Biologics Inc.
- Precision Biologics Inc. - Overview
- Precision Biologics Inc. - Product / Service
- Precision Biologics Inc. - Key offerings
- 12.16 Samsung Electronics Co. Ltd.
- Samsung Electronics Co. Ltd. - Overview
- Samsung Electronics Co. Ltd. - Business segments
- Samsung Electronics Co. Ltd. - Key news
- Samsung Electronics Co. Ltd. - Key offerings
- Samsung Electronics Co. Ltd. - Segment focus
- 12.17 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 13.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 13.4 Research methodology
- Research methodology
- 13.5 Data procurement
- Information sources
- 13.6 Data validation
- Data validation
- 13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 13.8 Data synthesis
- Data synthesis
- 360 degree market analysis
- 360 degree market analysis
- 13.10 List of abbreviations
- List of abbreviations
샘플 요청 목록